Johnson & Johnson (NYSE: JNJ) is a healthcare giant that sells over-the-counter products, pharmaceuticals, and medical devices. Its diversification makes it a core holding for many investors, including income investors who love its …
Tyler Durden: Perhaps the only chart more troubling than Johnson & Johnson’s (NYSE:JNJ) stock price in 2015, …
JNJ reported Q3 earnings last month ... those repurchased shares would have otherwise received. The stock also trades at about 15x earnings, net of excess cash on the balance sheet – an ostensibly fair price to pay. Perhaps this was also a …
Johnson & Johnson (NYSE:JNJ) is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company. The stock was down 0.69% at the top of the noon hour on February 6. Shares have …
At Johnson & Johnson, the world’s largest health care company, products or business that aren’t top performers aren’t lasting very long. About 70 percent of sales come from assets that were either No. 1 or No. 2 in their category. Last …
Shares closed up 0.9% at $112.80 on Wednesday and were indicated down 0.5% at $112.28 on Thursday. Johnson &
Johnson & Johnson’s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense. The $21.3 billion deal will give Johnson & Johnson a leading position in the main orthopedic device markets. …